SANOFI Stock Overview
Manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 3/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
Sanofi India Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹8,627.30 |
| 52 Week High | ₹9,380.00 |
| 52 Week Low | ₹6,755.05 |
| Beta | 0.34 |
| 1 Month Change | -0.58% |
| 3 Month Change | -1.06% |
| 1 Year Change | 23.12% |
| 3 Year Change | 11.20% |
| 5 Year Change | 58.72% |
| Change since IPO | 2,722.15% |
Recent News & Updates
Sanofi India (NSE:SANOFI) Will Pay A Dividend Of ₹117.00
Apr 26
Sanofi India (NSE:SANOFI) Will Pay A Dividend Of ₹117.00
Apr 12Recent updates
Sanofi India (NSE:SANOFI) Will Pay A Dividend Of ₹117.00
Apr 26Sanofi India (NSE:SANOFI) Will Pay A Dividend Of ₹117.00
Apr 12Sanofi India (NSE:SANOFI) Is Due To Pay A Dividend Of ₹117.00
Mar 29Sanofi India's (NSE:SANOFI) Dividend Will Be ₹117.00
Mar 09Risks To Shareholder Returns Are Elevated At These Prices For Sanofi India Limited (NSE:SANOFI)
Dec 21Is Sanofi India (NSE:SANOFI) A Risky Investment?
May 26Does Sanofi India (NSE:SANOFI) Have A Healthy Balance Sheet?
May 10Sanofi India (NSE:SANOFI) Is Increasing Its Dividend To ₹490
Apr 02Sanofi India (NSE:SANOFI) Is Increasing Its Dividend To ₹490
Feb 25Estimating The Fair Value Of Sanofi India Limited (NSE:SANOFI)
Dec 10Shareholder Returns
| SANOFI | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -2.5% | -1.8% | -1.9% |
| 1Y | 23.1% | 51.6% | 41.0% |
Return vs Industry: SANOFI underperformed the Indian Pharmaceuticals industry which returned 51.6% over the past year.
Return vs Market: SANOFI underperformed the Indian Market which returned 41% over the past year.
Price Volatility
| SANOFI volatility | |
|---|---|
| SANOFI Average Weekly Movement | 4.0% |
| Pharmaceuticals Industry Average Movement | 5.8% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in IN Market | 9.5% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: SANOFI has not had significant price volatility in the past 3 months.
Volatility Over Time: SANOFI's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1956 | 2,651 | Rodolfo Hrosz | www.sanofiindialtd.com |
Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally. It provides pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, thrombosis, central nervous system, anti-infective, epilepsy, allergy and vitamins, antihistamines, and minerals and supplements under the Lantus, Toujeo, Clexane, Amaryl, Cardace, Targocid, Frisium, Combiflam, DePura, Allegra, and Avil brands through independent distributors. The company also exports its products.
Sanofi India Limited Fundamentals Summary
| SANOFI fundamental statistics | |
|---|---|
| Market cap | ₹198.92b |
| Earnings (TTM) | ₹5.49b |
| Revenue (TTM) | ₹28.47b |
36.2x
P/E Ratio7.0x
P/S RatioIs SANOFI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SANOFI income statement (TTM) | |
|---|---|
| Revenue | ₹28.47b |
| Cost of Revenue | ₹12.05b |
| Gross Profit | ₹16.42b |
| Other Expenses | ₹10.93b |
| Earnings | ₹5.49b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 238.42 |
| Gross Margin | 57.68% |
| Net Profit Margin | 19.29% |
| Debt/Equity Ratio | 1.9% |
How did SANOFI perform over the long term?
See historical performance and comparison